Taking your medicine? Attitudes toward direct-to-consumer advertising (DTCA)

Social Science Journal

Volumn 50, Issue 4, 2013, Pages 501-509

  Ceccoli, Stephen J ^a   Klotz, Robert J ^b  

^a RHODES COLLEGE   (United States)

^b UNIVERSITY OF SOUTHERN MAINE   (United States)

Author keywords

Doctor patient relationship; DTCA; Food and Drug Administration; Prescription medicines; Public opinion

Indexed keywords

EID: 84888299746     PISSN: 03623319     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soscij.2013.02.002     Document Type: Article

References (56)

1. Alperstein N., Peyrot M. Consumer awareness of prescription drug advertising. Journal of Advertising Research 1993, 33:50-56.
2. An S. Attitude toward direct-to-consumer advertising and drug inquiry intention: The moderating role of perceived knowledge. Journal of Health Communication 2007, 12:567-580.
3. Auton F. The advertising of pharmaceuticals direct to consumers: A critical review of the literature and debate. International Journal of Advertising 2004, 23:5-52.
4. Baca E., Holguin J., Stratemeyer A. Direct-to-consumer advertising and young consumers: Building brand value. Journal of Consumer Marketing 2005, 22:379-387.
5. Beisecker A., Beisecker T. Using metaphors to characterize doctor-patient relationships: Paternalism versus consumerism. Health Communication 1993, 5:41-58.
6. Bell R., Kravitz R., Wilkes M. Direct-to-consumer prescription drug advertising and the public. Journal of General Internal Medicine 1999, 14:651-657.
7. Braithwaite R., Taylor S., Treadwell H. Health issues in the black community 2009, Jossey-Bass, San Francisco. 3rd ed.
8. Byrd W., Clayton L. An American health dilemma: A medical history of African Americans and the problem of race, beginning to 1900 2000, Routledge, New York.
9. Calfee J. Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy and Marketing 2002, 21:174-193.
10. Ceccoli S. Pill politics: Drugs and the FDA 2004, Lynne Rienner Publishers, Boulder.
11. Charles C., Gafni A., Whelan T. Decision-making in the physician-patient encounter: Revisiting the shared treatment decision-making model. Social Science and Medicine 1999, 49:651-661.
12. Choi S.M., Lee W.-N. Understanding the impact of direct-to-consumer (DTC) pharmaceutical advertising on patient-physician interactions. Journal of Advertising 2007, 36:137-149.
13. Cline R., Young H. Direct-to-consumer print ads for drugs: Do they undermine the physician-patient relationship?. The Journal of Family Practice 2005, 54:1049-1057.
14. Deshpande A., Menon A., Perri M., Zinkhan G. Direct-to-consumer advertising and its utility in health care decision-making: A consumer perspective. Journal of Health Communication 2004, 9:499-513.
15. Elliott S. Pharmaceutical makers and ad agencies fight to preserve campaigns for prescription drugs. The New York Times 2002, July 12, pC2.
16. Emanuel E., Emanuel L. Four models of the physician-patient relationship. JAMA 1992, 267:2221-2226.
17. Farris P., Wilkie W. Marketing scholars' roles in the policy arena: An opportunity for discourse on direct-to-consumer advertising. Journal of Public Policy and Marketing 2005, 24:3-6.
18. Fischer M., Albers S. Patient- or physician-oriented marketing: What drives primary demand for prescription drugs?. Journal of Marketing Research 2010, 47:103-121.
19. Foley L. The medication information gap: Older consumers in the void between direct-to-consumer advertising. Generations 2000/2001, 24:49-54.
20. Frosch D., Grande D., Tarn D., Kravitz R. A decade of controversy: Balancing policy with evidence in the regulation of prescription drug advertising. American Journal of Public Health 2010, 100:24-32.
21. Gönül F., Carter F., Wind J. What kind of patients and physicians value direct-to-consumer advertising of prescription drugs. Health Care Management 2000, 3:215-226.
22. Harris Interactive. (2005). Majority of U.S. adults think it is a good idea to forbid direct-to-consumer advertising for new prescription drugs when they first come to market. July 21.
23. Herzenstein M., Misra S., Posavac S. How consumers' attitudes toward direct-to-consumer advertising of prescription drugs influence ad effectiveness, and consumer and physician behavior. Marketing Letters 2004, 15:201-212.
24. Huh J., Becker L. Direct-to-consumer prescription drug advertising: Understanding its consequences. International Journal of Advertising 2005, 24:441-466.
25. Huh J., DeLorme D., Reid L. The information utility of DTC prescription drug advertising. Journalism and Mass Communication Quarterly 2004, 81:788-806.
26. IMS Health. (2012). Total US promotional spend by type, 2011. (accessed 11.09.12). http://www.imshealth.com/.
27. Ipsos. (2005). Is direct to consumer advertising putting more Americans at risk? Despite the recent heavy scrutiny, consumers continue to support Rx advertising. Press Release, April 28.
28. Jaramillo D. Pills gone wild: Medium specificity and the regulation of prescription drug advertising on television. Television and New Media 2006, 7:261-281.
29. Jones S., Mullan J. Older adults' perceptions and understanding of direct-to-consumer advertising. Journal of Consumer Marketing 2006, 23:6-14.
30. Joseph M., Stone G., Haper J., Stockwell E., Johnson K., Huckaby J. The effect of manufacturer-to-consumer prescription drug advertisements: An exploratory investigation. Journal of Medical Marketing 2005, 5:233-244.
31. Joseph M., Spake D., Finney Z. Consumer attitudes toward pharmaceutical direct-to-consumer advertising: An empirical study and the role of income. International Journal of Pharmaceutical and Healthcare Marketing 2008, 2:117-133.
32. Kaiser Family Foundation Public and physician views of direct-to-consumer prescription drug advertising. Kaiser Spotlight 2008.
33. Kaiser Family Foundation Impact of direct-to-consumer advertising on prescription drug spending 2003.
34. Klotz R., Ceccoli S. Media coverage of drug approvals. Social Science Journal 2005, 42:129-134.
35. Kravitz R. Direct to consumer advertising of prescription drugs: Implications for the physician-patient relationship [editorial]. JAMA 2000, 284:2244.
36. Lo B. Impact of the internet and advertising on patients and physicians, 2000-2001. Computer file 2004, ICPSR, Ann Arbor, MI.
37. Long S., Freese J. Regression models for categorical dependent variables using Stata 2006, Stata Press, College Station, TX. 2nd ed.
38. Mintzes B., Barer M., Kravitz R., Kazanjian A., Bassett K., Lexchin J., Evans R., Pan R., Marion S. Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: Two site cross sectional survey. BMJ 2002, 324:278-279.
39. O'Hara K. Is banning direct-to-consumer advertising consistent with bioethical principles?. Journal of the American Academy of Physician Assistants 2010, 23:54-56.
40. Parsons T. The social system 1951, The Free Press, Glencoe, IL.
41. Parsons T. The sick role and the role of the physician reconsidered. Millbank Memorial Fund Quarterly 1975, 53:257-278.
42. Paul D., Handlin A., Stanton A.D. Primary care physicians' attitudes toward direct-to-consumer advertising of prescription drugs: Still crazy after all these years. The Journal of Consumer Marketing 2002, 19:564-574.
43. Pew Internet & American Life Project. (2011). Health topics. February 1.
44. Pines W. A history and perspective on direct-to-consumer promotion. Food and Drug Law Journal 1999, 54:489-518.
45. Robinson A., Hohmann K., Rifkin J., Topp D., Gilroy C., Pickard J., Anderson R. Direct-to-consumer pharmaceutical advertising: Physician and public opinion and potential effects on the physician-patient relationship. Archives of Internal Medicine 2004, 164:427-432.
46. Rodale Inc. (2010). Prevention Magazine Releases 13th Annual DTC Survey Results. Press Release. July 15.
47. Science Advisory Board. (2003). Direct-to-consumer pharmaceutical advertising on the web (accessed 11.09.12). http://www.scienceboard.net/studies/studies.asp%3FstudyID=28.
48. Singh T., Smith D. Direct-to-consumer prescription drug advertising: A study of consumer attitudes and behavioral intentions. Journal of Consumer Marketing 2005, 22:369-378.
49. Stevenson F., Barry C., Britten N., Barber N., Bradley C. Doctor-patient communication about drugs: The evidence for shared decision making. Social Science and Medicine 2000, 50:829-840.
50. Thaul, S. (2009). Direct-to-consumer advertising of prescription drugs. CRS Report 7-5700. Congressional Research Service.
51. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. (1997). Draft guidance for industry on consumer-directed broadcast advertisements. Federal Register, 62(155), 43171-43173. August 12, Docket 97D-0302.
52. Viale P., Yamamoto D. The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications. Oncology Nursing Forum 2004, 31:777-784.
53. Wilkes M., Bell R., Kravitz R. Direct to consumer prescription drug advertising: Trends, impact and implications. Health Affairs 2000, 19:110-128.
54. Williams J., Hensel P. Direct-to-consumer advertising of prescription drugs. Journal of Health Care Marketing. 1995, 15:35-41.
55. Yang Y., Gourley D., Gourley G., Faris R. African American patients' attitudes toward proactive health behaviors after exposure to direct-to-consumer advertising. Journal of the National Medical Association 2010, 102:408-415.
56. Zaller J. The nature and origins of mass opinion 1992, Cambridge University Press, Cambridge.